Monthly Archives: December 2018

Anika to Showcase HYALOFAST at the International Cartilage Regeneration and Joint Preservation Society (ICRS) Focus Meeting in Milan

December 12, 2018 BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, today announced plans to showcase its entire Orthobiologics franchise, including HYALOFAST, at the upcoming ICRS Focus Meeting in Milan, Italy at the Humanitas Research University. The ICRS is the

By |2018-12-12T16:45:29+00:00December 12th, 2018|Biologics|
Read More

DJO Announces New Global Headquarters in Dallas, Texas to Accommodate Growth and Accelerate Innovation

December 12, 2018 DALLAS--(BUSINESS WIRE)--DJO (“DJO” or the “Company”), a leading global provider of medical technologies designed to get and keep people moving, today announced its plans to relocate its global headquarters from San Diego, California to Dallas, Texas by early 2019. DJO’s Bracing and Supports business unit, which develops and markets DonJoy®, the market-leading

By |2018-12-12T16:03:28+00:00December 12th, 2018|Extremities|
Read More

Kinamed’s CarboJet® System Employed in Study Showing Tourniquetless Total Knee Arthroplasty Decreases Pain and Opioid Consumption in Women

CAMARILLO, CALIF. (PRWEB) DECEMBER 11, 2018 A new clinical study published in the Journal of Arthroplasty comparing total knee replacement (TKR) surgery with and without use of the traditional thigh tourniquet demonstrated that female patients in the no-tourniquet group experienced significantly less post-operative pain and consumed fewer opioids as compared to female patients in the tourniquet

By |2018-12-12T15:10:28+00:00December 12th, 2018|Recon|
Read More

DiscGenics Receives Approval from Japanese Pharmaceuticals and Medical Devices Agency to Begin Clinical Evaluation of Non-Surgical Degenerative Disc Disease Treatment in Japan

SALT LAKE CITY, Dec. 11, 2018 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved a Clinical Trial Notification (CTN) application for IDCT, an allogeneic injectable

By |2018-12-11T21:16:30+00:00December 11th, 2018|Biologics|
Read More

In2Bones Expands Its Lead in PEEK Lower Extremity Implants with the Global Launch of the Unique PitStop® Subtalar Implant

December 11, 2018 MEMPHIS, Tenn.--(BUSINESS WIRE)--In2Bones Global, Inc. today announced the global launch of the unique, “see-through” PitStop®implant. Manufactured from a high-performance polymer called polyether ether ketone (PEEK), the PitStop® Implant is used to help facilitate the surgical correction of progressive flat foot deformity in both pediatric and adult populations. Flexible flatfoot is one of the most common deformities

By |2018-12-11T20:28:51+00:00December 11th, 2018|Extremities, Top Stories|
Read More

Institutional Investors to Pump $200B More Into Healthcare Infrastructure

By Fred Donovan December 10, 2018 - Global institutional investors are forecast to increase their investment in healthcare infrastructure by $200 billion over the next five years. For its report, the Octopus Group surveyed more than 100 global institutional investors with a total of $6.8 trillion in assets under management. The institutions said they currently allocated 6.1 percent of

By |2018-12-11T18:10:28+00:00December 11th, 2018|Financial|
Read More

The $49 billion/year of waste in healthcare spending we can solve

December 8, 2018 / Peter Nichol It is estimated that 30% of healthcare costs are lost to waste in the system. These costs get passed on to the insurer and ultimately the patients. With healthcare bills being the leading cause of personal bankruptcies in the country (60%) that 30% is the difference between solvency and destitution

By |2018-12-10T16:33:10+00:00December 10th, 2018|Financial|
Read More

Successful First in Human for ZygoFix’s Spinal Facet Joint Fixation System

MISGAV, Israel, Dec. 10, 2018 /PRNewswire/ -- ZygoFix Ltd. ("ZygoFix"), a portfolio company of The Trendlines Group Ltd.("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced the successful start of a first In human clinical study for its zLOCK spinal facet joint fixation system. The clinical study comprised several procedures to date and a 6-month follow-up of the first case. The first case, a

By |2018-12-10T15:37:55+00:00December 10th, 2018|Spine|
Read More

NuVasive Grows Cervical Spinal Interbody Portfolio With PEEK Corpectomy Implant

SAN DIEGO, Dec. 10, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded use of its Monolith®Corpectomy System, providing surgeons with a modular PEEK interbody solution for

By |2018-12-10T15:24:11+00:00December 10th, 2018|Regulatory, Spine, Top Stories|
Read More

MinInvasive Announces Successful Limited Market Release with OmniCuff™ System in the US

Magal, Israel, December 7, 2018 – MinInvasive Ltd., developer of the OmniCuff™ device for treatment of rotator cuff repair, reported positive progress following its initial two months of limited market release activity in the US with 26 OmniCuff™ System cases successfully concluded to date. Shoulder rotator cuff repair is a fast-growing market segment within the

By |2018-12-07T16:35:36+00:00December 7th, 2018|Sports Medicine|
Read More
Odysseus Medical Solutions 2018
RssEmail